Abstract:Efficient intracellular delivery of biologically active macromolecules has been a challenging but important process for manipulating live cells for research and therapeutic purposes. There have been limited transfection techniques that can deliver multiple types of active molecules simultaneously into single-cells as well as different types of molecules into physically connected individual neighboring cells separately with high precision and low cytotoxicity. Here, a high frequency ultrasound-based remote intr… Show more
“…The cell uptake of lipopolyplexes is based on its architecture, average particle size, and zeta potential of the complex formed. [ 38 ] Unlikely, the transfection of DPPC/CH/DPPG/PEG40S lipopolyplexes (LPP2) at mass ratio 0.5 was increased up to 20‐fold than polyplexes. The lower transfection efficiency was observed because liposomes may not coat polyplexes completely at mass ratio < 0.5, while a decrease in transfection efficiency at mass ratio > 0.5 could be due to aggregation of the particles at lower zeta potential.…”
Section: Resultsmentioning
confidence: 99%
“…[ 40,41 ] Taken together, the ultrasound enhances the transfection of ultrasound activated lipopolyplexes. [ 38,42 ] There is enhanced cell transfection of the carrier when the time difference between transfection and ultrasound treatment is ≥1 h.…”
This work focuses on the development of ultrasound contrast vesicles for ultrasound‐mediated enhanced transfection of nucleic acids in the cancer cells and projects its application as a tool for diagnostic imaging. The ultrasound contrast vesicles are stable, anionic, nanoscaled vesicles with ultrasound contrast equivalent to the commercially available SonoVue. These anionic lipid vesicles establish electrostatic interaction with cationic polyplexes based on linear polyethylenimine (22kDa) forming lipopolyplexes with ultrasound contrast. The lipopolyplexes are characterized regarding shape, size, and zeta potential. When exposed to low frequency ultrasound, these carriers show elevated transfection efficiency and reduced cytotoxicity. The effect of post‐transfection ultrasound on cellular uptake of lipopolyplexes is also evaluated. An analogous transfection is also observed in the tumor mimicking multicellular 3D spheroid culture of ovarian cancer cells. The emergence of tumor imaging and enhanced gene delivery by medical ultrasound, a noninvasive imaging modality, is considered paving the way for efficient theranostic gene therapy.
“…The cell uptake of lipopolyplexes is based on its architecture, average particle size, and zeta potential of the complex formed. [ 38 ] Unlikely, the transfection of DPPC/CH/DPPG/PEG40S lipopolyplexes (LPP2) at mass ratio 0.5 was increased up to 20‐fold than polyplexes. The lower transfection efficiency was observed because liposomes may not coat polyplexes completely at mass ratio < 0.5, while a decrease in transfection efficiency at mass ratio > 0.5 could be due to aggregation of the particles at lower zeta potential.…”
Section: Resultsmentioning
confidence: 99%
“…[ 40,41 ] Taken together, the ultrasound enhances the transfection of ultrasound activated lipopolyplexes. [ 38,42 ] There is enhanced cell transfection of the carrier when the time difference between transfection and ultrasound treatment is ≥1 h.…”
This work focuses on the development of ultrasound contrast vesicles for ultrasound‐mediated enhanced transfection of nucleic acids in the cancer cells and projects its application as a tool for diagnostic imaging. The ultrasound contrast vesicles are stable, anionic, nanoscaled vesicles with ultrasound contrast equivalent to the commercially available SonoVue. These anionic lipid vesicles establish electrostatic interaction with cationic polyplexes based on linear polyethylenimine (22kDa) forming lipopolyplexes with ultrasound contrast. The lipopolyplexes are characterized regarding shape, size, and zeta potential. When exposed to low frequency ultrasound, these carriers show elevated transfection efficiency and reduced cytotoxicity. The effect of post‐transfection ultrasound on cellular uptake of lipopolyplexes is also evaluated. An analogous transfection is also observed in the tumor mimicking multicellular 3D spheroid culture of ovarian cancer cells. The emergence of tumor imaging and enhanced gene delivery by medical ultrasound, a noninvasive imaging modality, is considered paving the way for efficient theranostic gene therapy.
“…We have developed an ultrasound technique to deliver macromolecules into target cells in vitro [43, 44]. Ultra-high frequency ultrasound beam can mechanically disrupt cell membrane to increase permeability of cells.…”
Section: The Application Of Ultrasound To Cellular Engineeringmentioning
From basic studies in understanding the role of signaling pathways to therapeutic applications in engineering new cellular functions, efficient and safe techniques to monitor and modulate molecular targets from cells to organs have been extensively developed. The developmental advancement of engineering devices such as microscope and ultrasonic transducers allows us to investigate biological processes at different scales. Synthetic biology has further emerged recently as a powerful platform for the development of new diagnostic and therapeutic molecular tools. The synergetic amalgamation between engineering tools and synthetic biology has rapidly become a new front in the field of bioengineering and biotechnology. In this review, ultrasound and its generated mechanical perturbation are introduced to serve as a non-invasive engineering approach and, integrated with synthetic biology, to remotely control signaling and genetic activities for the guidance of cellular functions deep inside tissue with high spatiotemporal resolutions. This ultrasound-based approach together with synthetic biology has been applied in immunotherapy, neuroscience, and gene delivery, paving the way for the development of next-generation therapeutic tools.
“…Single cell targeting and manipulation can be realized by HFU due to its focusing ability. When the frequency of HFU exceeds 150 MHz, the size of the focal area approaches that of a subcellular region smaller than 10 μm [ 26 , 27 ]. HFU can be used to mimic the physiological cues that trigger changes in gene expression and cell behavior.…”
Fluorescence resonance energy transfer (FRET)-based biosensors have advanced live cell imaging by dynamically visualizing molecular events with high temporal resolution. FRET-based biosensors with spectrally distinct fluorophore pairs provide clear contrast between cells during dual FRET live cell imaging. Here, we have developed a new FRET-based Ca2+ biosensor using EGFP and FusionRed fluorophores (FRET-GFPRed). Using different filter settings, the developed biosensor can be differentiated from a typical FRET-based Ca2+ biosensor with ECFP and YPet (YC3.6 FRET Ca2+ biosensor, FRET-CFPYPet). A high-frequency ultrasound (HFU) with a carrier frequency of 150 MHz can target a subcellular region due to its tight focus smaller than 10 µm. Therefore, HFU offers a new single cell stimulations approach for FRET live cell imaging with precise spatial resolution and repeated stimulation for longitudinal studies. Furthermore, the single cell level intracellular delivery of a desired FRET-based biosensor into target cells using HFU enables us to perform dual FRET imaging of a cell pair. We show that a cell pair is defined by sequential intracellular delivery of the developed FRET-GFPRed and FRET-CFPYPet into two target cells using HFU. We demonstrate that a FRET-GFPRed exhibits consistent 10–15% FRET response under typical ionomycin stimulation as well as under a new stimulation strategy with HFU.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.